THE MONTREAL DEFINITION IDENTIFIES MOST PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE IN A PRIMARY CARE POPULATION

(1) UNIVERSITY OF WISCONSIN

(2) Royal Adelaide Hospital & University of Adelaide

(3) AstraZeneca R&D



This item was part of the Oesophageal, Gastric and Duodenal Disorders I session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A157